Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour.
D'Ambrosio L, Palesandro E, Boccone P, Tolomeo F, Miano S, Galizia D, Manca A, Chiara G, Bertotto I, Russo F, Campanella D, Venesio T, Sangiolo D, Pignochino Y, Siatis D, De Simone M, Ferrero A, Pisacane A, Dei Tos AP, Aliberti S, Aglietta M, Grignani G. D'Ambrosio L, et al. Among authors: galizia d. Eur J Cancer. 2017 Jun;78:122-132. doi: 10.1016/j.ejca.2017.03.025. Epub 2017 Apr 24. Eur J Cancer. 2017. PMID: 28448856
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.
Pignochino Y, Capozzi F, D'Ambrosio L, Dell'Aglio C, Basiricò M, Canta M, Lorenzato A, Vignolo Lutati F, Aliberti S, Palesandro E, Boccone P, Galizia D, Miano S, Chiabotto G, Napione L, Gammaitoni L, Sangiolo D, Benassi MS, Pasini B, Chiorino G, Aglietta M, Grignani G. Pignochino Y, et al. Among authors: d ambrosio l, galizia d. Mol Cancer. 2017 Apr 28;16(1):86. doi: 10.1186/s12943-017-0652-5. Mol Cancer. 2017. PMID: 28454547 Free PMC article.
Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study.
Galizia D, Milani A, Geuna E, Martinello R, Cagnazzo C, Foresto M, Longo V, Berchialla P, Solinas G, Calori A, Grasso B, Volpone C, Bertola G, Parola G, Tealdi G, Giuliano PL, Ballari AM, Aglietta M, Montemurro F. Galizia D, et al. Cancer Med. 2018 Sep;7(9):4339-4344. doi: 10.1002/cam4.1687. Epub 2018 Jul 20. Cancer Med. 2018. PMID: 30030895 Free PMC article.
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Petrelli A, Bellomo SE, Sarotto I, Kubatzki F, Sgandurra P, Maggiorotto F, Di Virgilio MR, Ponzone R, Geuna E, Galizia D, Nuzzo AM, Medico E, Miglio U, Berrino E, Venesio T, Ribisi S, Provero P, Sapino A, Giordano S, Montemurro F. Petrelli A, et al. Among authors: galizia d. ESMO Open. 2020 Oct;5(5):e000937. doi: 10.1136/esmoopen-2020-000937. ESMO Open. 2020. PMID: 33122354 Free PMC article.
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.
Merlano MC, Abbona A, Paccagnella M, Falletta A, Granetto C, Ricci V, Fea E, Denaro N, Ruatta F, Merlotti A, Bertetto O, Crosetto N, Galizia D, Basiricò M, Gammaitoni L, Sangiolo D, Aglietta M, Garrone O. Merlano MC, et al. Among authors: galizia d. Vaccines (Basel). 2021 Mar 8;9(3):235. doi: 10.3390/vaccines9030235. Vaccines (Basel). 2021. PMID: 33800511 Free PMC article.
28 results